StockWatch
·
ROSSTECH · Q2 FY-2027 · THE VERDICT

Record revenue, compressed margins, semicon growth claim overstated

Q2 revenue hit a record ₹186 Cr (+48% YoY), driving 70% PAT growth, but EBITDA margin at 15.6% fell short of both prior 17–22% and new 18–23% guidance. Semicon growth claim of 3–4x contradicted by actual ~40% YoY delivery.

Q2 FY27 resultsROSSTECHRossell Techsys Ltd12 Nov 2026 · 6 min read
Q2 Revenue

₹186 Cr

+48% YoY, record high

Q2 PAT

₹9.7 Cr

+70% YoY, but NPM 5.1%

Q2 EBITDA margin

15.6%

vs 17–22% prior, 18–23% new

H1 Revenue

₹345 Cr

+60% YoY

On the headline numbers, it looks like a blowout quarter. Revenue hit a record ₹186 crore, up 48% year-on-year. Profit surged 70%. But the call revealed the real story — and it's more complicated. The quarter proved two pieces of guidance wrong: the EBITDA margin target and the semicon growth claim. That's not a miss in execution; that's a miss in credibility.

Where the profit really comes from

PAT of ₹9.7 crore looks strong in isolation, but the profit margin tells the real story. Net profit margin is just 5.1% — compressed by finance costs. Management disclosed interest outgo of approximately ₹9.7 crore in Q2, almost exactly equal to reported PAT. That means underlying operating profit (before interest) is roughly ₹19.4 crore, not ₹9.7 crore. The company's profitability is being masked by debt. The good news: ₹300 crore was raised in a QIP (anchored by SBI MF and Kotak MF); management promised 'substantial' interest cost relief starting in Q3 from debt repayment. The bad news: until that happens, the profit story is understated.

The margin miss

EBITDA margin of 15.6% in Q2 is the core issue. In the prior call (FY26), management guided for 17–22% EBITDA margins 'as the benefits of recent investments are realized.' This call they revised upward to 18–23%, citing scale benefits. But Q2 actual of 15.6% falls 1.4 to 7.4 percentage points short of both targets. Analyst Nisarg Shah pressed directly: 'Previous calls guided 17–20% EBITDA margins; are we on that trajectory with operating leverage?' Management replied: 'Yes, definitely... we're well on track to achieve that' (the 18–23% target). But the numbers don't support that claim yet. At the current margin, delivering 18–23% by year-end would require a 240–450 basis point improvement in H2 — a jump management hasn't quantified or explained.

The semicon growth claim

The prior call (FY26) included bold guidance: '300–400% expansion in the semiconductor and space segments.' This quarter, that guidance quietly evaporated. When analyst Darshil Jhaveri asked directly, 'Were targeting 3–4x growth in space/semicon; how is that segment doing?' management said: 'On track for that kind of growth. ... ₹140 crore non-aero in H1 vs ₹100 crore last year between semicon and space.' That's a 40% year-on-year growth rate — nowhere close to 3–4x. Management cited two very large multinational OEM customers now on board (up from one), which is genuine progress. But the growth rate contradicts the prior guidance by an order of magnitude. Analysts didn't follow up; management didn't acknowledge the gap. That's the credibility issue.

Management claims vs. what held up
Claim on the callDelivered / RealityVerdict
Record ₹186 Cr revenueDelivered ₹186 Cr; confirmed highest ever quarterlySupported
EBITDA margin 'on track' to 18–23%Q2 at 15.6%; 1.4–7.4pp below targetContradicted
3–4x growth in semiconductors and spaceNon-aero segment ~40% YoY (₹100 Cr → ₹140 Cr H1)Overstated
Operating leverage and scale benefits deliveringRevenue +48% YoY but margin compressed from prior guideOverstated
Fresh orders ₹430 Cr, bids ₹1,350 Cr in H1Stated; no contradicting data in resultSupported

What changed on this call

Semicon customer base expanded. Now partnering with two 'very large respected multinationals' in semicon (vs. prior single customer). This is genuine progress for diversification, but growth rate (40% YoY) falls far short of the 3–4x target.

Capital structure strengthened. ₹300 crore QIP completed successfully with strong institutional demand (SBI MF, Kotak MF anchor). Proceeds earmarked for debt repayment (working capital borrowings) and growth capex. Interest cost savings promised to be 'substantial' and visible in Q3.

New facility going live Q3. 140,000–210,000 sq ft Aerospace Park facility being inaugurated early next quarter, with expansion option to 210k sq ft. Designed to support semicon, non-defense, and MRO scaling. This is the capacity lever for the 50/50 split (aerospace / non-aero) targeted by year-end.

FY27 guidance hedged / withdrawn. Prior call: 87% FY27 revenue growth. This call: No numeric FY27 target given. H1 at 60% growth; management deflected quantification to 'Q3/Q4 historically strongest quarters.' Analyst Darshil Jhaveri pressed: 'Alluded to 80%+ growth previously; H1 at 60%; what is FY27 revenue guidance?' Management declined: 'Can't give exact forward-looking numbers.' That's a red flag when you're mid-year at 60% and the prior target was 87%.

The bull-bear ledger
  • Record quarterly revenue (₹186 Cr) and strong PAT growth (+70% YoY)

  • Order book ₹3.9k Cr (₹910 Cr confirmed + ₹3.1k Cr strategic); 12–16 quarter visibility

  • Semicon customer base expanded to 2 major OEMs; diversification underway

  • ₹300 Cr capital raise completed; balance sheet de-risked

  • New facility (140k–210k sq ft) live Q3; MRO and semicon scaling capacity unlocked

  • Inventory efficiency improving (7.98 → 6.67 months; target 4 months)

  • EBITDA margin 15.6% vs 17–22% prior and 18–23% new target; repeated miss

  • Interest burden (~₹9.7 Cr) equals Q2 PAT; masks underlying operating profit

  • Semicon 3–4x growth claim contradicted by actual ~40% YoY delivery

  • FY27 guidance withdrawn mid-year despite 60% H1 growth (below 87% prior target)

  • Margin expansion and interest relief both unproven and unquantified

Risks, ranked by how much they should concern a holder

Key risks and why they matter

Margin expansion stalled

High

Q2 EBITDA margin 15.6% vs 18–23% target; no timeline given. If Q3/Q4 don't deliver 240–450 bps improvement, the bull case (scale benefits) is broken.

Interest burden unresolved until Q3

High

Finance costs ~₹9.7 Cr (= Q2 PAT) mask underlying profitability. Relief promised for Q3 but unquantified. If relief is <₹5 Cr, interest remains a headwind.

Semicon growth underperformance

Medium

3–4x claim vs 40% YoY delivery. If growth stalls or customer concentration risk materializes (2 OEMs), the non-aero diversification thesis fails.

FY27 guidance credibility damaged

Medium

87% prior target; 60% H1; no FY27 number given. If H2 growth doesn't re-accelerate, full-year misses and analyst confidence erodes.

Facility ramp-up execution

Medium

New 140k–210k sq ft facility live 'early Q3.' Delays or quality issues could stall semicon/MRO scaling.

How the street is positioned

The stock is at ₹1,429, down 15.87% from its all-time high of ₹1,699. That drawdown reflects market caution — and it's justified. The stock is near its 20-day moving average (₹1,430), holding above the 50-day (₹1,394) and well above the 200-day (₹1,018). RSI is 51.1 (neutral), suggesting no oversold bounce imminent. Volume is normal; no capitulation selling. Ownership is locked in: promoter stake 74.80% (unchanged for 6+ quarters), FII 1.68% (+8 bps quarter-on-quarter), DII 0.78% (-273 bps QoQ). The DII selling is worth noting — domestic institutions trimmed in Q1 FY27, suggesting they're waiting for margin proof before re-engaging. No insider selling near the highs, and no bulk/block deals in the past six months. The market has priced in margin and guidance concerns; a positive Q3 (facility ramp, margin improvement, interest relief) would likely re-rate the stock.

What to watch next
  • 1 · Q3 EBITDA margin delivery

    Is it 16–17% (modest improvement)? 18%+? The 18–23% target is only credible if Q3 shows material progression. A margin flat or down QoQ would be disqualifying.

  • 2 · Interest cost reduction post-capital redeployment

    Management promised 'substantial' Q3 relief from ₹300 Cr debt repayment. Quantify it: if interest drops to ₹5 Cr or less, the underlying PAT story strengthens. If it stays at ₹7–9 Cr, the profit recovery is weaker than promised.

  • 3 · Facility ramp-up and semicon/MRO contribution

    New 140k–210k sq ft facility live 'early Q3.' Did it come on-line? Is semicon revenue accelerating into H2? Any MRO wins or Boeing/US aftermarket traction materializing?

  • 4 · Semicon 3–4x growth narrative

    Does non-aero revenue jump in H2? If it stays at 40% YoY growth, the 3–4x claim is officially dead and customer concentration risk rises. If it accelerates to 60%+ YoY, the narrative survives (barely).

Rossell delivered record revenue and strong profit growth, but the call proved two key pieces of guidance wrong: the EBITDA margin target and the semicon growth rate. That's a pattern of credibility erosion, not a one-time miss. The stock's 15.87% drawdown from ATH is justified — the market is right to be cautious. The bull case (structural order book, semicon diversification, capacity unlock) is still intact, but it's now on probation. The bar for the next quarter is high: Q3 must deliver 18%+ EBITDA margin, visible interest cost relief, and a credible path to 50/50 split by year-end. If management executes, the stock re-rates. If margins stay compressed and guidance continues to slip, the correction deepens. Hold. The number to track from here is Q3 EBITDA margin — it's the tell.

Informational and educational content only. Not investment advice.